CC

CROSBY Co OF NEW HAMPSHIRE LLC

Long-term holder

Total reported value

Reporting period: 2026-03-31 · Number of holdings: 1

CROSBY Co OF NEW HAMPSHIRE LLC disclosed 1 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of — and a quarterly turnover rate of 0.0%.

Personality snowflake

Concentration
0
Portfolio Stability
0
Momentum/Contrarian
50
Sector conviction
0
Diversification
2
Sizing Uniformity

Recent moves

  • Unchanged 000000000

     $0.0

Holdings Map

Top 10 holdings by weight

Full holdings list this quarter

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1Ikena Oncology INCStock-Other

Holding changes this quarter

Position changes disclosed by CROSBY Co OF NEW HAMPSHIRE LLC for the quarter ending 2026-03-31, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction
1Ikena Oncology INCUnchanged

FAQ

What is CROSBY Co OF NEW HAMPSHIRE LLC and what type of investor is it?
CROSBY Co OF NEW HAMPSHIRE LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.
What are CROSBY Co OF NEW HAMPSHIRE LLC's largest equity positions?
Based on the latest 13F filing, CROSBY Co OF NEW HAMPSHIRE LLC's top holdings by market value are: 1. Ikena Oncology INC — $0.0
What changes did CROSBY Co OF NEW HAMPSHIRE LLC make in its most recent portfolio filing?
No notable portfolio changes were recorded for CROSBY Co OF NEW HAMPSHIRE LLC in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does CROSBY Co OF NEW HAMPSHIRE LLC focus on?
Sector breakdown data is not yet available for CROSBY Co OF NEW HAMPSHIRE LLC. Check back after the next 13F processing cycle.